SCTX insider trading — Scribe Therapeutics, Inc.
Over the last 90 days, insiders at Scribe Therapeutics, Inc. (SCTX) made 6 open-market purchases worth $56.34M and 0 open-market sales worth $0, making them net buyers by $56.34M. The largest purchase was by Aghazadeh Behzad, Avoro Capital Advisors Llc, Avoro Ventures Llc (Director), who bought 2,383,333 shares for $36.12M on Jul 24, 2026. 5 different insiders bought shares in this period — a cluster buy, which many investors watch closely.
Updated Oct 16, 2026.
Recent SCTX insider transactions
Every Form 4 filed by Scribe Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Ah Bio Fund Ii, L.P., Ah Equity Partners Bio Ii, L.L.C., Ah Bio Fund Iii, L.P., Ah Equity Partners Bio Iii, L.L.C., Andreessen Marc L, Horowitz Benjamin A | 10% Owner | C · Conversion | Indirect | 2,749,392 | — | — | Form 4 |
| Jul 27, 2026 | Ah Bio Fund Ii, L.P., Ah Equity Partners Bio Ii, L.L.C., Ah Bio Fund Iii, L.P., Ah Equity Partners Bio Iii, L.L.C., Andreessen Marc L, Horowitz Benjamin A | 10% Owner | P · Purchase | Indirect | 333,333 | $15.00 | $5.00M | Form 4 |
| Jul 27, 2026 | Gordon Carl L | Director | C · Conversion | Indirect | 348,825 | — | — | Form 4 |
| Jul 27, 2026 | Gordon Carl L | Director | P · Purchase | Indirect | 1,000,000 | $15.00 | $15.00M | Form 4 |
| Jul 27, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Viii Llc | Director | C · Conversion | Indirect | 348,825 | — | — | Form 4 |
| Jul 27, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Viii Llc | Director | P · Purchase | Indirect | 1,000,000 | $15.00 | $15.00M | Form 4 |
| Jul 27, 2026 | Doudna Jennifer A | 10% Owner | C · Conversion | Direct | 12,511 | — | — | Form 4 |
| Jul 28, 2026 | Aghazadeh Behzad, Avoro Capital Advisors Llc, Avoro Ventures Llc | Director | P · Purchase | Indirect | 7,905 | $18.25 | $144K | Form 4 |
| Jul 24, 2026 | Aghazadeh Behzad, Avoro Capital Advisors Llc, Avoro Ventures Llc | Director | P · Purchase | Indirect | 2,383,333 | $15.15 | $36.12M | Form 4 |
| Jul 23, 2026 | Lucas Svetlana | Chief Business Officer | P · Purchase | Indirect | 3,000 | $15.00 | $45K | Form 4 |
| Jul 23, 2026 | Parrot David | Chief Financial Officer | P · Purchase | Indirect | 2,666 | $15.00 | $40K | Form 4 |
SCTX insider trading FAQ
Are insiders buying SCTX stock?
Yes. In the last 90 days, Scribe Therapeutics, Inc. insiders made 6 open-market purchases totaling $56.34M, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading SCTX?
Recent buyers: Aghazadeh Behzad, Avoro Capital Advisors Llc, Avoro Ventures Llc, Ah Bio Fund Ii, L.P., Ah Equity Partners Bio Ii, L.L.C., Ah Bio Fund Iii, L.P., Ah Equity Partners Bio Iii, L.L.C., Andreessen Marc L, Horowitz Benjamin A, Gordon Carl L, Lucas Svetlana, Parrot David.
Where does SCTX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.